Skip to search formSkip to main contentSkip to account menu

GSK343

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
背景与目的 肺癌是危害身体健康的常见恶性肿瘤之一。随着表观遗传学的发展,研究者发现Zeste基因增强子同源物基因2(enhancer of Zeste homolog 2, EZH2)在肺癌中高表达且其表达量与预后息息相关,与此同时EZH2… 
2017
2017
OBJECTIVE To explore the therapeutic effect of enhancer of Zeste homolog 2 (EZH2) inhibitor GSK343 on periodontitis by regulating… 
Review
2016
Review
2016
This editorial draws attention to the work published by CEPP in 2014–2015 on mechanisms underlying cancer drug resistance… 
2016
2016
Enhancer of zeste homolog 2 (EZH2) has been emerged as novel anticancer target. Various EZH2 small-molecule inhibitors have been… 
2016
2016
Cigarette smoke is an environmental risk factor for COPD and Lung cancer, leading causes of morbidity and mortality worldwide. In… 
2015
2015
INTRODUCTION: Ependymoma is the second most common malignant paediatric tumour of the central nervous system, accounting for 6-12… 
2014
2014
The enhancer of zeste homolog 2 (EZH2) has emerged as a novel anticancer target. Various EZH2 inhibitors have been developed in… 
2014
2014
Genetic alterations of epigenetic regulators have become a recurrent theme in hematological malignancies. In particular… 
2013
2013
The EZH2 histone methyltransferase is the enzymatic core of the Polycomb repressor 2 (PRC2 complex), is highly upregulated in… 
2013
2013
Histone methyltransferases (HMT) are chromatin modifiers that regulate the transcriptomic landscape in normal development as well…